New York State Teachers Retirement System cut its stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 0.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 63,807 shares of the biotechnology company's stock after selling 534 shares during the period. New York State Teachers Retirement System owned about 0.08% of Axon Enterprise worth $52,828,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in AXON. TCTC Holdings LLC grew its position in Axon Enterprise by 75.0% in the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock worth $29,000 after acquiring an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC boosted its position in Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after buying an additional 33 shares during the period. Banque Transatlantique SA purchased a new stake in Axon Enterprise during the first quarter valued at about $31,000. Catalyst Capital Advisors LLC purchased a new stake in Axon Enterprise during the first quarter valued at about $32,000. Finally, Flaharty Asset Management LLC purchased a new stake in Axon Enterprise during the first quarter valued at about $33,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other Axon Enterprise news, President Joshua Isner sold 15,919 shares of the company's stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $746.26, for a total value of $11,879,712.94. Following the sale, the president owned 238,379 shares in the company, valued at approximately $177,892,712.54. This represents a 6.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Brittany Bagley sold 5,000 shares of the company's stock in a transaction dated Monday, September 29th. The stock was sold at an average price of $713.88, for a total transaction of $3,569,400.00. Following the completion of the sale, the chief financial officer owned 93,592 shares in the company, valued at approximately $66,813,456.96. This trade represents a 5.07% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 59,932 shares of company stock valued at $45,115,616. Insiders own 4.40% of the company's stock.
Axon Enterprise Price Performance
AXON stock opened at $652.17 on Friday. Axon Enterprise, Inc has a 1 year low of $422.38 and a 1 year high of $885.91. The company has a market cap of $51.20 billion, a P/E ratio of 161.03, a PEG ratio of 25.05 and a beta of 1.41. The firm has a 50-day moving average of $742.88 and a 200 day moving average of $716.37. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping analysts' consensus estimates of $1.54 by $0.58. The business had revenue of $668.54 million for the quarter, compared to analysts' expectations of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business's revenue was up 32.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. On average, sell-side analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on AXON. JMP Securities reaffirmed a "market outperform" rating and set a $825.00 price objective on shares of Axon Enterprise in a research note on Monday, September 29th. Needham & Company LLC reaffirmed a "buy" rating and set a $870.00 price objective on shares of Axon Enterprise in a research note on Wednesday, September 24th. Wolfe Research began coverage on shares of Axon Enterprise in a research note on Monday, July 7th. They set an "outperform" rating for the company. JPMorgan Chase & Co. upped their price objective on shares of Axon Enterprise from $730.00 to $850.00 and gave the company an "overweight" rating in a research note on Thursday, July 17th. Finally, Zacks Research downgraded shares of Axon Enterprise from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, September 2nd. Fourteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $841.64.
Check Out Our Latest Stock Report on Axon Enterprise
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.